A Risk Assessment For Acasti
Summary ACST has been riding on the success of AMRN in the past year; however, several risk factors have cropped up. A review of past data suggests...
Summary ACST has been riding on the success of AMRN in the past year; however, several risk factors have cropped up. A review of past data suggests...
Summary Significant growth in the prescription Omega 3 (Rx OM3) drug market. CaPre’s® has the potential to be the "best in class" Rx OM3. Over the ...